Company page

Starpharma Holdings Limited

Starpharma Holdings Limited, trading under the ticker SPL, is a public company based in Australia with a market capitalization of approximately AUD 206.49 million. The company focuses on developing innovative pharmaceutical products using its proprietary dendrimer technology. Starpharma aims to enhance drug delivery and improve therapeutic outcomes in various medical applications.